早产儿视网膜病变治疗后黄斑发育研究现状及进展
Recent advances in foveal development after treatment for retinopathy of prematurity
摘要早产儿视网膜病变(ROP)是一种增生性血管性视网膜疾病,冷冻治疗、激光光凝治疗、玻璃体腔注射抗血管内皮生长因子(VEGF)药物治疗、巩膜扣带手术和玻璃体切割手术等是其主要治疗手段。接受非手术治疗后的ROP患儿的黄斑中心凹厚度都相对增厚,中心凹形态和黄斑区视网膜血管发育受到影响,导致视力发育的异常。但目前有关ROP各种治疗手段影响黄斑发育的具体机制尚不明确,眼内VEGF水平的变化是否改变了正常黄斑发育的过程以及黄斑发育异常具体又如何影响视功能等问题,尚需进一步大样本量的研究来加以证实及探索。
更多相关知识
abstractsRetinopathy of prematurity (ROP) is a proliferative vascular retinal disease. Cryotherapy, laser photocoagulation, intravitreal injection of anti-vascular endothelial growth factor, scleral buckling surgery and vitrectomy are the main treatments. Treated with cryotherapy or laser photocoagulation or intravitreal injection of anti-vascular endothelial growth factor, patients with a history of ROP have thicker foveas, and the morphology of the fovea and the development of the retinal vessels in the macular area are affected, resulting in abnormal vision development. However, the specific mechanisms by which different treatments of ROP affecting the development of the macula are not yet clear. It still need further study with large samples to verify and explore, whether changes in the levels of intraocular vascular endothelial growth factor changing the process of normal macular development and how the abnormal development of the macula affects visual function.
More相关知识
- 浏览253
- 被引0
- 下载158

相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文